vs

Side-by-side financial comparison of CHICAGO RIVET & MACHINE CO (CVR) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.

CHICAGO RIVET & MACHINE CO is the larger business by last-quarter revenue ($6.0M vs $5.0M, roughly 1.2× cbdMD, Inc.). cbdMD, Inc. runs the higher net margin — -5.6% vs -19.3%, a 13.7% gap on every dollar of revenue. On growth, CHICAGO RIVET & MACHINE CO posted the faster year-over-year revenue change (45.9% vs -1.9%). CHICAGO RIVET & MACHINE CO produced more free cash flow last quarter ($24.3K vs $-977.3K). Over the past eight quarters, cbdMD, Inc.'s revenue compounded faster (7.1% CAGR vs -12.7%).

Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.

cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.

CVR vs YCBD — Head-to-Head

Bigger by revenue
CVR
CVR
1.2× larger
CVR
$6.0M
$5.0M
YCBD
Growing faster (revenue YoY)
CVR
CVR
+47.8% gap
CVR
45.9%
-1.9%
YCBD
Higher net margin
YCBD
YCBD
13.7% more per $
YCBD
-5.6%
-19.3%
CVR
More free cash flow
CVR
CVR
$1.0M more FCF
CVR
$24.3K
$-977.3K
YCBD
Faster 2-yr revenue CAGR
YCBD
YCBD
Annualised
YCBD
7.1%
-12.7%
CVR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CVR
CVR
YCBD
YCBD
Revenue
$6.0M
$5.0M
Net Profit
$-1.2M
$-283.1K
Gross Margin
2.7%
59.8%
Operating Margin
-15.3%
-5.7%
Net Margin
-19.3%
-5.6%
Revenue YoY
45.9%
-1.9%
Net Profit YoY
68.0%
-1975.7%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVR
CVR
YCBD
YCBD
Q4 25
$6.0M
$5.0M
Q3 25
$7.4M
$4.7M
Q2 25
$7.3M
$4.6M
Q1 25
$7.2M
$4.7M
Q4 24
$4.1M
$5.1M
Q3 24
$7.0M
$4.6M
Q2 24
$8.1M
$5.2M
Q1 24
$7.9M
$4.4M
Net Profit
CVR
CVR
YCBD
YCBD
Q4 25
$-1.2M
$-283.1K
Q3 25
$67.6K
$-680.0K
Q2 25
$-395.0K
$-895.3K
Q1 25
$401.0K
$-480.8K
Q4 24
$-3.6M
$15.1K
Q3 24
$-1.4M
$-152.8K
Q2 24
$142.1K
$459.7K
Q1 24
$-698.0K
$-3.0M
Gross Margin
CVR
CVR
YCBD
YCBD
Q4 25
2.7%
59.8%
Q3 25
18.1%
58.8%
Q2 25
13.4%
61.5%
Q1 25
22.9%
62.3%
Q4 24
-43.7%
66.5%
Q3 24
10.0%
53.9%
Q2 24
17.6%
65.8%
Q1 24
9.5%
59.0%
Operating Margin
CVR
CVR
YCBD
YCBD
Q4 25
-15.3%
-5.7%
Q3 25
0.9%
-14.5%
Q2 25
-5.7%
-19.6%
Q1 25
1.0%
-10.2%
Q4 24
-86.4%
-1.7%
Q3 24
-11.8%
-6.9%
Q2 24
1.3%
-7.4%
Q1 24
-11.5%
-35.4%
Net Margin
CVR
CVR
YCBD
YCBD
Q4 25
-19.3%
-5.6%
Q3 25
0.9%
-14.4%
Q2 25
-5.4%
-19.4%
Q1 25
5.5%
-10.1%
Q4 24
-88.0%
0.3%
Q3 24
-20.8%
-3.4%
Q2 24
1.8%
8.9%
Q1 24
-8.9%
-68.8%
EPS (diluted)
CVR
CVR
YCBD
YCBD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-0.15
Q1 24
$-1.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVR
CVR
YCBD
YCBD
Cash + ST InvestmentsLiquidity on hand
$1.7M
$3.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$18.8M
$9.0M
Total Assets
$23.3M
$11.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVR
CVR
YCBD
YCBD
Q4 25
$1.7M
$3.4M
Q3 25
$1.7M
$2.3M
Q2 25
$1.2M
$1.1M
Q1 25
$765.6K
$1.8M
Q4 24
$2.2M
$2.0M
Q3 24
$2.2M
$2.5M
Q2 24
$2.6M
$2.4M
Q1 24
$2.7M
$2.1M
Total Debt
CVR
CVR
YCBD
YCBD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CVR
CVR
YCBD
YCBD
Q4 25
$18.8M
$9.0M
Q3 25
$20.0M
$7.2M
Q2 25
$20.0M
$6.1M
Q1 25
$20.4M
$665.8K
Q4 24
$20.0M
$1.8M
Q3 24
$23.7M
$2.0M
Q2 24
$25.2M
$3.0M
Q1 24
$25.2M
$3.1M
Total Assets
CVR
CVR
YCBD
YCBD
Q4 25
$23.3M
$11.8M
Q3 25
$24.0M
$10.4M
Q2 25
$23.6M
$9.9M
Q1 25
$24.1M
$10.9M
Q4 24
$23.4M
$11.5M
Q3 24
$26.4M
$10.6M
Q2 24
$27.3M
$13.8M
Q1 24
$27.8M
$14.6M
Debt / Equity
CVR
CVR
YCBD
YCBD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVR
CVR
YCBD
YCBD
Operating Cash FlowLast quarter
$116.4K
$-812.5K
Free Cash FlowOCF − Capex
$24.3K
$-977.3K
FCF MarginFCF / Revenue
0.4%
-19.5%
Capex IntensityCapex / Revenue
1.5%
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.6M
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVR
CVR
YCBD
YCBD
Q4 25
$116.4K
$-812.5K
Q3 25
$638.0K
$-240.7K
Q2 25
$28.2K
$-704.2K
Q1 25
$-2.0M
$-189.5K
Q4 24
$-60.1K
$-317.9K
Q3 24
$-58.2K
$167.4K
Q2 24
$363.5K
$289.8K
Q1 24
$-398.8K
$-704.1K
Free Cash Flow
CVR
CVR
YCBD
YCBD
Q4 25
$24.3K
$-977.3K
Q3 25
$492.1K
$-243.6K
Q2 25
$-22.8K
$-705.7K
Q1 25
$-2.1M
$-205.0K
Q4 24
$-118.1K
$-482.3K
Q3 24
$-368.9K
$157.4K
Q2 24
$58.0K
Q1 24
$-491.8K
$-708.7K
FCF Margin
CVR
CVR
YCBD
YCBD
Q4 25
0.4%
-19.5%
Q3 25
6.7%
-5.2%
Q2 25
-0.3%
-15.3%
Q1 25
-28.3%
-4.3%
Q4 24
-2.9%
-9.4%
Q3 24
-5.3%
3.5%
Q2 24
0.7%
Q1 24
-6.3%
-16.2%
Capex Intensity
CVR
CVR
YCBD
YCBD
Q4 25
1.5%
3.3%
Q3 25
2.0%
0.1%
Q2 25
0.7%
0.0%
Q1 25
0.6%
0.3%
Q4 24
1.4%
3.2%
Q3 24
4.5%
0.2%
Q2 24
3.8%
0.0%
Q1 24
1.2%
0.1%
Cash Conversion
CVR
CVR
YCBD
YCBD
Q4 25
Q3 25
9.44×
Q2 25
Q1 25
-5.01×
Q4 24
-21.06×
Q3 24
Q2 24
2.56×
0.63×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVR
CVR

Fastener$5.1M85%
Other$890.7K15%

YCBD
YCBD

Sales Channel Directly To Consumer$3.6M72%
Sales Channel Through Intermediary$1.4M28%

Related Comparisons